AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary

The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal can...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2021-12, Vol.161 (6), p.2030-2040.e1
Hauptverfasser: Wang, Andrew Y., Hwang, Joo Ha, Bhatt, Amit, Draganov, Peter V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2040.e1
container_issue 6
container_start_page 2030
container_title Gastroenterology (New York, N.Y. 1943)
container_volume 161
creator Wang, Andrew Y.
Hwang, Joo Ha
Bhatt, Amit
Draganov, Peter V.
description The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal cancers with endoscopic submucosal dissection deemed to be pathologically curative. This Clinical Practice Update was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors, who are advanced endoscopists with high-level expertise in performing endoscopic submucosal dissection to treat dysplasia and early cancers in the luminal gastrointestinal tract.
doi_str_mv 10.1053/j.gastro.2021.08.058
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2585906049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016508521034867</els_id><sourcerecordid>2585906049</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-206d12a9c6bce20a012c605b620c91c9cd205cd9b8d7e0a0cc80b0f5e22d25a23</originalsourceid><addsrcrecordid>eNp9UcFu1DAUtBCILoU_QMhHLgkv3jhNOCCt0mWLVEGl0rPl2C-tV0kcbGel_hWfyNtu4cjpSfbMvHkzjL0vIC9Arj_t83sdU_C5AFHkUOcg6xdsVUhRZwCFeMlWNKpMQi3P2JsY9wDQrOviNTtbl1XdNFW5Yr83uw1vBzc5owd-E7RJziC_m61OyP3Eb5dwQDcMeqLnTZ8w8BudHvzg74-U4ZG3S9DJHZBvJ-uj8bMzxOrGxfhImpcuRiRV0vI93-pAlN2TczcljMlNBPqOfh50dJq7iacHMjC5hJbfJrIRP_PWjyNOSYfHt-xVr4eI757nObv7uv3ZXmXXP3bf2s11ZsqLMmUCKlsI3ZiqMyhAUyCmAtlVAkxTmMZYAdLYpqvtBdK3MTV00EsUwgqpxfqcfTzpzsH_WsinGl00eAwC_RKVkLVsoIKyIWh5gprgYwzYqzm4kbyqAtSxK7VXp67UsSsFtaKuiPbheQOFhfYf6W85BPhyAiDdeXAYVDQOqQfrAiWqrHf_3_AHKZyrcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2585906049</pqid></control><display><type>article</type><title>AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Alma/SFX Local Collection</source><creator>Wang, Andrew Y. ; Hwang, Joo Ha ; Bhatt, Amit ; Draganov, Peter V.</creator><creatorcontrib>Wang, Andrew Y. ; Hwang, Joo Ha ; Bhatt, Amit ; Draganov, Peter V.</creatorcontrib><description>The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal cancers with endoscopic submucosal dissection deemed to be pathologically curative. This Clinical Practice Update was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors, who are advanced endoscopists with high-level expertise in performing endoscopic submucosal dissection to treat dysplasia and early cancers in the luminal gastrointestinal tract.</description><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><identifier>DOI: 10.1053/j.gastro.2021.08.058</identifier><identifier>PMID: 34689964</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biopsy - standards ; Cancer ; Clinical Decision-Making ; Consensus ; Curative Resection ; Diagnostic Imaging - standards ; Dysplasia ; Early Detection of Cancer - standards ; Endoscopic Mucosal Resection - adverse effects ; Endoscopic Mucosal Resection - standards ; Endoscopy, Gastrointestinal - standards ; ESD ; Gastroenterology - standards ; Gastrointestinal Neoplasms - diagnostic imaging ; Gastrointestinal Neoplasms - pathology ; Gastrointestinal Neoplasms - surgery ; Humans ; Margins of Excision ; Neoplasm Staging ; Predictive Value of Tests ; Surveillance ; Time Factors ; Treatment Outcome ; United States</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2021-12, Vol.161 (6), p.2030-2040.e1</ispartof><rights>2021 AGA Institute</rights><rights>Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-206d12a9c6bce20a012c605b620c91c9cd205cd9b8d7e0a0cc80b0f5e22d25a23</citedby><cites>FETCH-LOGICAL-c474t-206d12a9c6bce20a012c605b620c91c9cd205cd9b8d7e0a0cc80b0f5e22d25a23</cites><orcidid>0000-0002-6519-7882</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.gastro.2021.08.058$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34689964$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Andrew Y.</creatorcontrib><creatorcontrib>Hwang, Joo Ha</creatorcontrib><creatorcontrib>Bhatt, Amit</creatorcontrib><creatorcontrib>Draganov, Peter V.</creatorcontrib><title>AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary</title><title>Gastroenterology (New York, N.Y. 1943)</title><addtitle>Gastroenterology</addtitle><description>The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal cancers with endoscopic submucosal dissection deemed to be pathologically curative. This Clinical Practice Update was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors, who are advanced endoscopists with high-level expertise in performing endoscopic submucosal dissection to treat dysplasia and early cancers in the luminal gastrointestinal tract.</description><subject>Biopsy - standards</subject><subject>Cancer</subject><subject>Clinical Decision-Making</subject><subject>Consensus</subject><subject>Curative Resection</subject><subject>Diagnostic Imaging - standards</subject><subject>Dysplasia</subject><subject>Early Detection of Cancer - standards</subject><subject>Endoscopic Mucosal Resection - adverse effects</subject><subject>Endoscopic Mucosal Resection - standards</subject><subject>Endoscopy, Gastrointestinal - standards</subject><subject>ESD</subject><subject>Gastroenterology - standards</subject><subject>Gastrointestinal Neoplasms - diagnostic imaging</subject><subject>Gastrointestinal Neoplasms - pathology</subject><subject>Gastrointestinal Neoplasms - surgery</subject><subject>Humans</subject><subject>Margins of Excision</subject><subject>Neoplasm Staging</subject><subject>Predictive Value of Tests</subject><subject>Surveillance</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>United States</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcFu1DAUtBCILoU_QMhHLgkv3jhNOCCt0mWLVEGl0rPl2C-tV0kcbGel_hWfyNtu4cjpSfbMvHkzjL0vIC9Arj_t83sdU_C5AFHkUOcg6xdsVUhRZwCFeMlWNKpMQi3P2JsY9wDQrOviNTtbl1XdNFW5Yr83uw1vBzc5owd-E7RJziC_m61OyP3Eb5dwQDcMeqLnTZ8w8BudHvzg74-U4ZG3S9DJHZBvJ-uj8bMzxOrGxfhImpcuRiRV0vI93-pAlN2TczcljMlNBPqOfh50dJq7iacHMjC5hJbfJrIRP_PWjyNOSYfHt-xVr4eI757nObv7uv3ZXmXXP3bf2s11ZsqLMmUCKlsI3ZiqMyhAUyCmAtlVAkxTmMZYAdLYpqvtBdK3MTV00EsUwgqpxfqcfTzpzsH_WsinGl00eAwC_RKVkLVsoIKyIWh5gprgYwzYqzm4kbyqAtSxK7VXp67UsSsFtaKuiPbheQOFhfYf6W85BPhyAiDdeXAYVDQOqQfrAiWqrHf_3_AHKZyrcw</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Wang, Andrew Y.</creator><creator>Hwang, Joo Ha</creator><creator>Bhatt, Amit</creator><creator>Draganov, Peter V.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6519-7882</orcidid></search><sort><creationdate>202112</creationdate><title>AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary</title><author>Wang, Andrew Y. ; Hwang, Joo Ha ; Bhatt, Amit ; Draganov, Peter V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-206d12a9c6bce20a012c605b620c91c9cd205cd9b8d7e0a0cc80b0f5e22d25a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biopsy - standards</topic><topic>Cancer</topic><topic>Clinical Decision-Making</topic><topic>Consensus</topic><topic>Curative Resection</topic><topic>Diagnostic Imaging - standards</topic><topic>Dysplasia</topic><topic>Early Detection of Cancer - standards</topic><topic>Endoscopic Mucosal Resection - adverse effects</topic><topic>Endoscopic Mucosal Resection - standards</topic><topic>Endoscopy, Gastrointestinal - standards</topic><topic>ESD</topic><topic>Gastroenterology - standards</topic><topic>Gastrointestinal Neoplasms - diagnostic imaging</topic><topic>Gastrointestinal Neoplasms - pathology</topic><topic>Gastrointestinal Neoplasms - surgery</topic><topic>Humans</topic><topic>Margins of Excision</topic><topic>Neoplasm Staging</topic><topic>Predictive Value of Tests</topic><topic>Surveillance</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Andrew Y.</creatorcontrib><creatorcontrib>Hwang, Joo Ha</creatorcontrib><creatorcontrib>Bhatt, Amit</creatorcontrib><creatorcontrib>Draganov, Peter V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Andrew Y.</au><au>Hwang, Joo Ha</au><au>Bhatt, Amit</au><au>Draganov, Peter V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><addtitle>Gastroenterology</addtitle><date>2021-12</date><risdate>2021</risdate><volume>161</volume><issue>6</issue><spage>2030</spage><epage>2040.e1</epage><pages>2030-2040.e1</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><abstract>The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to review the available evidence and provide expert advice regarding surveillance using endoscopy and other relevant modalities after removal of dysplastic lesions and early gastrointestinal cancers with endoscopic submucosal dissection deemed to be pathologically curative. This Clinical Practice Update was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors, who are advanced endoscopists with high-level expertise in performing endoscopic submucosal dissection to treat dysplasia and early cancers in the luminal gastrointestinal tract.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34689964</pmid><doi>10.1053/j.gastro.2021.08.058</doi><orcidid>https://orcid.org/0000-0002-6519-7882</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0016-5085
ispartof Gastroenterology (New York, N.Y. 1943), 2021-12, Vol.161 (6), p.2030-2040.e1
issn 0016-5085
1528-0012
language eng
recordid cdi_proquest_miscellaneous_2585906049
source MEDLINE; Elsevier ScienceDirect Journals; Alma/SFX Local Collection
subjects Biopsy - standards
Cancer
Clinical Decision-Making
Consensus
Curative Resection
Diagnostic Imaging - standards
Dysplasia
Early Detection of Cancer - standards
Endoscopic Mucosal Resection - adverse effects
Endoscopic Mucosal Resection - standards
Endoscopy, Gastrointestinal - standards
ESD
Gastroenterology - standards
Gastrointestinal Neoplasms - diagnostic imaging
Gastrointestinal Neoplasms - pathology
Gastrointestinal Neoplasms - surgery
Humans
Margins of Excision
Neoplasm Staging
Predictive Value of Tests
Surveillance
Time Factors
Treatment Outcome
United States
title AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T21%3A44%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AGA%20Clinical%20Practice%20Update%20on%20Surveillance%20After%20Pathologically%20Curative%20Endoscopic%20Submucosal%20Dissection%20of%20Early%20Gastrointestinal%20Neoplasia%20in%20the%20United%20States:%20Commentary&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=Wang,%20Andrew%20Y.&rft.date=2021-12&rft.volume=161&rft.issue=6&rft.spage=2030&rft.epage=2040.e1&rft.pages=2030-2040.e1&rft.issn=0016-5085&rft.eissn=1528-0012&rft_id=info:doi/10.1053/j.gastro.2021.08.058&rft_dat=%3Cproquest_cross%3E2585906049%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2585906049&rft_id=info:pmid/34689964&rft_els_id=S0016508521034867&rfr_iscdi=true